DAVI.US Davion Healthcare Plc Ordinary Shares
- Market cap
- USD 25.0M
- P/E
- -
- P/B
- 20.50x
- ROE
- -84.9%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is DAVI.US undervalued?
Graham numberThe Graham number of Davion Healthcare Plc Ordinary Shares cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Davion Healthcare Plc Ordinary Shares fundamental analysis
No fundamental analysis for Davion Healthcare Plc Ordinary Shares yet.
Davion Healthcare Plc Ordinary Shares stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Davion Healthcare Plc Ordinary Shares
Davion Healthcare Plc, a digital healthcare company, engages in the design, development, and commercialization of non-invasive health monitoring technologies. Its core consumer health portfolio comprises proprietary, home-based monitoring devices designed to support the early identification of potential medical anomalies. The company's flagship product, BreastCheck, is an FDA-registered at-home breast health screening test designed to identify potential abnormalities through…
Full company profileDavion Healthcare Plc Ordinary Shares financial statements
Davion Healthcare Plc Ordinary Shares annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Income Statement | |||
| Revenue | 0.00 | 0.00 | 0.00 |
| Operating Income | -5.31M | -1.63M | -1.13M |
| EBITDA | -5.31M | -1.32M | -824K |
| Net Income | -5.31M | -1.63M | -1.13M |
| EPS | -0.21 | -0.07 | -0.05 |
| Balance Sheet | |||
| Total Assets | 65.0M | 2.50M | 2.33M |
| Total Liabilities | 5.23M | 39.8K | 996K |
| Shareholders' Equity | 59.8M | 2.46M | 1.33M |
| Cash & Short-term Investments | 679.00 | 11.00 | 1.06K |
| Cash Flow | |||
| Operating Cash Flow | 679.00 | -668.00 | -323.00 |
| Capital Expenditure | 0.00 | 0.00 | 0.00 |
| Free Cash Flow | 679.00 | -668.00 | -323.00 |
| Ratios | |||
| ROE | -8.9% | -66.1% | -84.9% |
| ROA | -8.2% | -65.1% | -48.5% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
Davion Healthcare Plc Ordinary Shares dividends
Davion Healthcare Plc Ordinary Shares has not paid dividends in the last 3 fiscal years.
Who owns Davion Healthcare Plc Ordinary Shares
- Insiders 38.42%
- Institutions 0.00%
- Public & others 61.58%
- Shares outstanding 25.0M
- Free float 13.5M
Davion Healthcare Plc Ordinary Shares company profile
- Company name
- Davion Healthcare Plc Ordinary Shares
- Ticker
- DAVI.US
- Exchange
- USA Stocks
- Listed since
- Oct 22, 2026
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Fiscal year end
- December
- Address
- West Cork Business & Technology Park, Cork, Ireland, P85 FV48
- Phone
- 353 238 808 958
- Website
- davionhealthcare.com
About Davion Healthcare Plc Ordinary Shares
Davion Healthcare Plc, a digital healthcare company, engages in the design, development, and commercialization of non-invasive health monitoring technologies. Its core consumer health portfolio comprises proprietary, home-based monitoring devices designed to support the early identification of potential medical anomalies. The company's flagship product, BreastCheck, is an FDA-registered at-home breast health screening test designed to identify potential abnormalities through changes in breast temperature. It is also developing a portfolio of proprietary health monitoring technologies, including FootFlow for monitoring indicators associated with circulation and diabetes-related blood flow issues; Testic, an at-home testicular health monitoring system; and ThermaDerm for the identification of skin anomalies, as well as technologies addressing wound monitoring, blood pressure, and other areas of preventive healthcare. The company was incorporated in 2022 and is based in Cork, Ireland.
Davion Healthcare Plc Ordinary Shares management
4- Mr. Glenn WilliamsChief Executive Officer
- Mr. Andreas TtofiChief Financial Officer
- Mr. Jeremy NorthChief Operating Officer · born 1962
- Mr. David OverChief Commercial Officer & Director